Big changes are coming.
President Donald Trump has appointed Susan Monarez as the permanent director of the U.S. Centers for Disease Control and Prevention (CDC), following her interim leadership since January. If confirmed by the Senate, Monarez would be the first CDC head without a medical degree in more than 50 years. An infectious disease researcher by training, Monarez previously served as deputy director at a federal health research agency established during the Biden administration.
Trump’s decision to nominate Monarez follows the withdrawal of his original candidate, Dr. Dave Weldon, whose views on vaccines and lack of a strong agency plan were concerns for Senate Republicans. Monarez is expected to work closely with Health Secretary Robert F. Kennedy Jr. to combat chronic diseases and restore public trust in the CDC, an agency Trump claims has suffered from political bias and poor management.
Health experts generally view Monarez’s nomination positively, highlighting her expertise in infectious diseases and public health. Dr. Georges Benjamin, head of the American Public Health Association, expressed confidence in her abilities and emphasized her strong background in governmental public health. Monarez’s reputation as a capable researcher suggests she may bring a fresh approach to leading the agency.
However, some CDC staff have raised concerns about Monarez’s leadership style, as she has been working remotely rather than from the CDC’s headquarters in Atlanta. Employees have also noted limited communication from her office, with some frustrated by the lack of engagement. Her role in a cost-cutting initiative that could lead to significant changes at the CDC has added to staff unease.
Monarez also faced criticism for not opposing the removal of certain terms, such as “LGBTQ” and “transgender,” from CDC materials when requested. While many are optimistic about her leadership, some internal and external challenges remain as she prepares to take on the role permanently.
Discussion about this post